Signals
IAPM Launches Oncology Pillar at ASCO: Closing the Gap Between Cancer Breakthroughs and Patient Access
CHICAGO, June 2026: The International Alliance for Personalised Medicine launched its Oncology Pillar at ASCO with a packed room and a clear message: oncology science is advancing at extraordinary speed, but too many patients still face barriers to the tests, trials, and treatments that could change their lives.
WHA 2026: WHO resolution moves precision medicine onto the global health policy agenda
ASCO 2026: Pancreatic cancer gets its precision medicine moment
ASCO 2026: GI cancers are finally moving out of oncology’s blind spot
ASCO 2026: AI is entering cancer care before the rules are ready
ASCO 2026: Are we overtreating cancer?
ASCO 2026: Why oncology is also paying attention to GLP-1 medicines
AI Pathology Moves From Demo to Workflow
AlphaGenome Makes Variant Interpretation Political
The AMR Pipeline Is Too Thin for the Threat Ahead
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.